Recombinant adeno-associated virus for muscle directed gene therapy
β Scribed by Fisher, Krishna J.; Jooss, Karin; Alston, James; Yang, Yiping; Haecker, Sarah Ehlen; High, Katherine; Pathak, Ravindra; Raper, Steven E.; Wilson, James M.
- Book ID
- 109927700
- Publisher
- Nature Publishing Group
- Year
- 1997
- Tongue
- English
- Weight
- 998 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1078-8956
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background Recombinant adeno-associated virus (rAAV) is becoming a promising vector for gene therapy for type I diabetes. The objective of this study was to investigate the effect of incorporation of polyethylenimine (PEI) on rAAV-mediated insulin gene therapy in vitro and in vivo. ## Methods Rec
## Abstract To evaluate the tumoricidal activity of tumor necrosis factor (TNF)βrelated apoptosisβinducing ligand (TRAIL) on disseminated liver metastatic tumors, we constructed a recombinant adenoβassociated virus (rAAV) expressing the extracellular domain (95β281aa) of human TRAIL (TRAIL~95β281~,
## Abstract ## Background Viruses are being exploited as vectors to deliver therapeutic genetic information into target cells. The success of this approach will depend on the ability to overcome current limitations, especially in terms of safety and efficiency, through molecular engineering of the